Potential uses of Ustilago maydis

Keywords: Huitlacoche, medicinal mushrooms, antioxidant, edible mushrooms, nutrients

Abstract

Due to the high biodiversity of ecosystems in Mexico, there is a high variety of species, some of the most abundant are fungi, since there is a record of approximately 200 thousand endemic species in Mexico, traditionally the use given to these organisms It is nutritional and medicinal. One of the most characteristic species of our country is Ustilago maydis commonly known as huitlacoche, which presents various properties in its high nutritional value in amino acids, fats, antioxidants, proteins and its relevant use to treat different painful conditions, these applications have been demonstrated Due to the pharmaceutical and industrial interest that this species presents, however, different studies show that U. maydis could have potential biotechnological uses.

Downloads

Download data is not yet available.

References

Mittermeier R, Goettsch C, La importancia de la diversidad biológica de México. In México ante los retos de la biodiversidad, En: J. Sarukhán y R. Dirzo (comps.). Conabio 1992; 63-73.

Conabio. Expertos evalúan y enlistan hongos en riesgo de extinción de los bosques templados de México. Comisión Nacional para el Conocimiento y Uso de la Biodiversidad 2019; 341 p.

Plascencia RL, Castañón Barrientos A, Raz Guzmán A. La biodiversidad en México su conservación y las colecciones biológicas Ciencias,UNAM. 2011; 101 36-43

López Sánchez X O. Tierra de Hongos, CONABIO. 2022.

Aguirre Acosta Elvira, Ulloa Miguel, Aguilar Samuel, Cifuentes Joaquín, Valenzuela Ricardo. Biodiversidad de hongos en México. Rev. Mex. Biodiv. 2014; 85( Suppl ):S76-S81.

Guzmán G. Análisis cualitativo y cuantitativo de la diversidad de los hongos en México (Ensayo sobre el inventario fúngico del país). In La diversidad biológica de Iberoamérica II, G. Halffter (ed.). Acta Zoológica Mexicana, nueva serie vol. Especial, CYTED e Instituto de Ecología, Xalapa 1998; 111-75.

Guzmán, G. Diversity and use of traditional Mexican medicinal fungi. A review. Int J. Med. Mushrooms 2008; 10:209-17.

Barros L, Cruz T, Baptista P, Estevinho L, Ferreira I. Wild and commercial mushrooms as source of nutrients and nutraceuticals. Food Chem. Tox. 2008; 46:2742-47.

Yu-Cheng D, Zhu-Liang Y, Bao-Kai C, Chang Jun Y, Li-Wei Z. Species diversity and utilization of medicinal mushrooms and fungi in China (Review). Int. J. Med Mushrooms 2009; 11: 287-302.

Jiménez Ruiz M, Pérez Moreno J, Almaraz Suárez JJ, Torres Aquino M. Hongos silvestres con potencial nutricional, medicinal y biotecnológico comercializados en Valles Centrales, Oaxaca. Rev. Mex. Cienc. Agríc. 2013; 4(2): 199-213.

Aguayo González DJ, Guevara Lara F, Pérez Cabrera LE, García Munguía CA, Garcia AM. Patogenicidad de cepas de Ustilago maydis para la producción en condiciones controladas. Rev. Mex. Cienc. Agric. 2021; 12(3): 513–24

Banuett F. y Herskowitz, I. Discrete developmental stages during teliospore formation in the corn smut fungus, Ustilago maydis. Development 1996; 122: 2965-76.

Holliday, R. Ustilago maydis. in: Ed. King, R. C. editors. Handbook of Genetics. N.Y: Plenum Press 1974; (1): 575-95.

Ruiz Herrera J, León Ramírez C, Martínez Espinoza A D. Morphogenesis and pathogenesis in Ustilago maydis. Recent Res. Develop. Microbiol. 2000; 4: 585-98.

Biggs, A, Kapicka C. Lundgren L. Biología. La dinámica de la vida. México: McGraw-Hill; 2000.

Ruiz Herrera J, Ustilago maydis: ascenso de un hongo mexicano de la gastronomía local al mundo científico. Nova Scientia 2008; 1(1): 118-35.

Banuett F, Herskowitz I. Discrete developmental stages during teliospore formation in the corn smut fungus, Ustilago maydis. Development 1996; 122: 2965-76.

Martínez Martínez L, Villanueva Verduzco C, Sahagún Castellanos J. Susceptibility and resistance of maize to the edible fungus huitlacoche (Ustilago maydis Cda.) improving its virulence. Rev. Chap. Serie Hort. 2000; 6 (2): 241–55.

López Martínez L X, Aguirre Delgado A, Saenz Hidalgo H K, Buenrostro Figueroa J J, García H S, Baeza Jiménez R. Bioactive ingredients of huitlacoche (Ustilago maydis), a potential food raw material. Food Chem. Mol. Sci. 2022; 4: 100076.

Valdez Morales M, Barry K, Fahey GC, Jr Domínguez J, de Mejia EG, Valverde ME, Paredes López O. Effect of maize genotype, developmental stage, and cooking process on the nutraceutical potential of huitlacoche (Ustilago maydis). Food Chem. 2010; 119(2): 689-97.

Cereceres Aragón A, Rodríguez Tadeo A, Álvarez Parrilla E, Rodrigo García J. Ingestión de compuestos fenólicos en población adulta mayor. Nutr. Hosp. 2018; 36(2): 470–8.

Molina Montes ME, Martín Islán ÁP. Ácidos grasos esenciales. Omega-3 y Omega-6. Offarm. 2010; 29(1): 66–72.

Aydoğdu M, Gölükçü M. Nutritional value of huitlacoche, maize mushroom caused by Ustilago maydis. Food Scie. Tech. 2017; 37(4): 531–5.

Lizárraga Guerra R, López MG. Contenido de aminoácidos libres en Huitlacoche (Ustilago maydis) J. Agric. Quím. alim. 1996; 44: 2556–9.

Villagrán Z, Martínez Reyes M, Gómez Rodríguez H, Ríos-García U, Montalvo-González E, Ortiz-Basurto RI, et al. Huitlacoche (Ustilago maydis), an Iconic Mexican Fungal Resource: Biocultural Importance, Nutritional Content, Bioactive Compounds, and Potential Biotechnological Applications. Molecules. 2023; 29;28(11): 4415.

Martínez Flores A, Corrales García JJ. Espinosa Solares T. García Gatica P G, Villanueva Verduzco C. Postharvest changes in the edible mushroom huitlacoche (Ustilago maydis (D.C.) Corda). Rev. Chap. Serie Hort. 2018; 14(3): 339-46.

Valverde ME, Paredes López O. Production and evaluation of some food properties of huitlacoche (Ustilago maydis). Food Biotech. 1993; 7(3): 207-19.

Ayimbila F, Keawsompong S. Nutritional Quality and Biological Application of Mushroom Protein as a Novel Protein Alternative. Curr. Nutr. Rep. 2023; 12(2): 290-307.

Doll DN, Barr TL, Simpkins JW. Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets. Aging. Dis. 2014; 5(5): 294-306.

Banerjee A, Khemka VK, Roy D, Dhar A, Sinha Roy TK, Biswas A, et alt. Chakrabarti S. Role of Pro-Inflammatory Cytokines and Vitamin D in Probable Alzheimer's Disease with Depression. Aging. Dis. 2017; 2;8(3): 267-6.

Krenzischek DA, Wilson L, Newhouse R, Mamaril M, Kane HL. Clinical evaluation of the ASPAN Pain and Comfort. J. Perianesth Nurs. 2004; 19(3): 150-63.

Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R. et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain 2019; 160(1): 19-27.

Puebla Díaz F. Tipos de dolor y escala terapéutica de la O.M.S. Dolor iatrogénico. Oncología (Barc.). 2005; 28(3): 33-7.

Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011;152(3 Suppl):S2-S15.

Ghlichloo I, Gerriets, V. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). In StatPearls StatPearls Publishing . 2023.

Cabo de Villa ED, Morejón Hernández JM, Acosta Figueredo E. Dolor y analgésicos. Algunas consideraciones oportunas. Medisur. 2020; 18(4): 694-705.

Quiñonez Bastidas GN, Navarrete A. Mexican Plants and Derivates Compounds as Alternative for Inflammatory and Neuropathic Pain Treatment-A Review. Plants (Basel) 2021; 10(5): 865.

Venturella G, Ferraro V, Cirlincione F, Gargano M L. Medicinal mushrooms: Bioactive compounds, use, and clinical trials. Int. J. Mol. Scie. 2021; 22(2): 634.

Kurz M, Eder C, Isert D, Li Z, Paulus E F, Schiell M, et alt Ustilipids, acylated β-D-mannopyranosyl D-erythritols from Ustilago maydis and Geotrichum candidum. J. Antibiotics 2003; 56(2): 91-101.

Pimentel González DJ, Rodríguez Huezo ME, Campos Montiel RG, Trapala Islas A, Hernández Fuentes AD. Influence of corn variety on physicochemical characteristics of Huitlacoche (Ustilago maydis) Rev. Mex. Ing. Quim. 2011; 10: 171–8.

Wu H C, His H Y, Hsiao G, Yen C H, Leu J Y, Wu C C et al. Chemical constituents and bioactive principles from the Mexican truffle and fermented products of the derived fungus Ustilago maydis MZ496986. J. Agric. Food Chem. 2023; 71: 1122–31.

Juárez Montiel M, Ruiloba de León S, Chávez Camarillo G, Hernández Rodríguez C, Villa Tanaca L. Huitlacoche (corn smut), caused by the phytopathogenic fungus Ustilago maydis, as a functional food. Rev. iberoamer. micol. 2011; 2: 69–73.

Bautista González JA, Moreno Fuentes A. La Etnomicología en México. Edición cromada; Tamaulipas, México. Los hongos medicinales de México. 2015; 14-176.

Salazar López JM, Martínez Saldaña MC, Reynoso Camacho R, Chávez Morales RM, Sandoval Cardozo M L, Guevara Lara F. Antioxidant capacity and phytochemical characterization of ethanolic extracts from raw and cooked huitlacoche (Ustilago maydis-Zea mays) Rev. Mex. Cienc. Farm. 2017; 48: 37–47.

Bazzano LA, He J, Ogden LG, Loria CM, Vupputuri S, Myers L, et al. Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr. 2002; 76(1): 93–9.

Brighenti F, Valtueña S, Pellegrini N, Ardigò D, Del Rio D, Salvatore S, Piatti P, Serafini M, Zavaroni I. Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects. Br. J. Nutr. 2005; 93(5): 619-25.

Pitsavos C, Panagiotakos D B, Tzima N. Chrysοhoou C, Economou M, Zampelas A, Stefanadis C. Adherence to the Mediterranean diet is associated with total antioxidant capacity in healthy adults: the ATTICA study. Am. J. Clin. Nutr. 2005; 82(3): 694-99.

Katsnelson A, De Strooper B, Zoghbi HY. Neurodegeneration: from cellular concepts to clinical applications. Sci. Transl. Med. 2016; 8:364ps18.

Martínez Leo E E, Segura Campos M R. Systemic oxidative stress: a key point in neurodegeneration – a review. J Nutr. Health Aging. 2019; 23: 694–9.

Pegoretti V, Swanson KA, Bethea JR, Probert L, Eisel ULM, Fischer R. Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development. Oxid Med Cell Longev. 2020; 7191080.

Sienes Bailo P, Llorente Martín E, Calmarza P, Montolio Breva S, Bravo Gómez A, Pozo Giráldez A, et alt. Implicación del estrés oxidativo en las enfermedades neurodegenerativas y posibles terapias antioxidantes. Adv Lab Med. 2022; 3(4): 351–60.

Zúñiga E, García J. E. “El envejecimiento demográfico en México. Principales tendencias y características”, en La situación demográfica de México 2008, conapo, México.

González Cervantes ME, Hernández Uribe JP, Gómez Aldapa CA, Navarro Cortez RO, Palma Rodríguez HM, Vargas Torres A. Physicochemical, functional, and quality properties of fettuccine pasta added with huitlacoche mushroom (Ustilago maydis) J. Food Process. Preserv. 2021; 45: e15825.

Rosalba Beas F, Guadalupe Loarca P, Salvador Horacio Guzmán M, Rodriguez MG, Nora Lilia Vasco M, Fidel Guevara L. Nutraceutic potential of bioactive components present in huitlacoche from the central zone of Mexico. Rev. Mex. Cienc. Farm. 2011; 42: 36–44.

Estrada AF, Brefort T, Mengel C, Díaz Sánchez V, Alder A, Al Babili S, Avalos J. Ustilago maydis accumulates β-carotene at levels determined by a retinal-forming carotenoid oxygenase. Fungal Genet. Biol. 2009; 46: 803–13

Vezza T, Canet F, de Marañón AM, Bañuls C, Rocha M, Víctor VM. Phytosterols: Nutritional health players in the management of obesity and its related disorders. Antioxidants. 2020; 9: 1266.

Ras RT, Trautwein EA, Consumer purchase behaviour of foods with added phytosterols in six European countries: Data from a post-launch monitoring survey. Food Chem. Toxicol. 2017; 110: 42–8.

González A, Cruz M, Losoya C, Nobre C, Loredo A, Rodríguez R, Contreras J, Belmares R. Edible mushrooms as a novel protein source for functional foods. Food Funct. 2020;23;11(9):7400-14.

Scialabba NE-H. Managing health livestock production and consumption. 1st Ed. Academic Press; 2022. 107–21 p.

Santos A, Navascués E, Bravo E, Marquina D. Ustilago maydis killer toxin as a new tool for the biocontrol of the wine spoilage yeast Brettanomyces bruxellensis. Int. J. Food Microbiol. 2011; 31:145(1): 147-54.

Cortés Sánchez A, Hernández-Sánchez H, JaramilloFlores M. Production of glycolipids with antimicrobial activity by Ustilago maydis FBD12 in submerged culture. África J. Microbiol. Res. 2011; 5: 2512–23

Yang X L, Awakawa T, Wakimoto T, Abe I. Induced production of the novel glycolipid ustilagic acid C in the plant pathogen Ustilago maydis. Tetraedro. Lett. 2013; 54: 3655–57.

Becker F, Stehlik T, Linne U, Bölker M, Freitag J, Sandrock B. Engineering Ustilago maydis para la producción de lípidos de manosileritritol hechos a medida. Metab. Ing. Comunitario 2021; 12: e00165.

Valadez Azúa R, Moreno Fuentes Á, Gómez Álvarez G. Cuujtlacoche. 1ra ed. México: UNAM Instituto de investigaciones Antropológicas; 2011. 89, 104 p.

Published
2024-08-13
How to Cite
Ordoñez velázquez, I. iris. (2024). Potential uses of Ustilago maydis. Mexican Journal of Medical Research ICSA, 13(25). Retrieved from https://repository.uaeh.edu.mx/revistas/index.php/MJMR/article/view/12396